IVIG for refractory dysphagia in Antisynthetase syndrome: A truth hard to swallow.

Authors :: Alnoukari, Mais
De La Garza, Oziel Garza
Al Gburi, Karrar
Patel, Niral
Lopez, Henderson
Shamim, Muhammad
Kwang, Henry
Source :: Clinical Case Reports; Nov2022, Vol. 10 Issue 11, p1-4, 4p
Publication Year :: 2022
Abstract: Refractory dysphasia could be the main symptom of Antisynthetase syndrome (ASS). IVIG may have a major impact in the successful treatment of dysphasia in patients with ASS. In our patient with ASS, IVIG treatment was an unreplaceable treatment option, and the patient regains her ability to swallow within 2 days. Refractory dysphasia could be the main symptom of Antisynthetase syndrome (ASS). IVIG may have a major impact in the successful treatment of dysphasia in patients with ASS. A cure can be possible within just 2 days of IVIG treatment. [ABSTRACT FROM AUTHOR]

Subjects :: INTRAVENOUS immunoglobulins
TREATMENT effectiveness
SYNDROMES
APHASIA
DEGLUTITION

Full Text Access

Tools